TAS-116 Plus Palbociclib in Breast and Rb-null Cancer
- Status
- WITHDRAWN
- Phase
- PHASE1
Clinical Trials Related to SCLC
Related studies linked through entity extraction aliases.
Study of Oral MRT-2359 in Selected Cancer Patients
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
GD2-SADA:177Lu-DOTA Complex in Patients With Solid Tumors Known to Express GD2
- Status
- RECRUITING
- Phase
- PHASE1
A Study of IBI110 in Combination With Sintilimab and Chemotherapy in Patients With Untreated Extensive-Stage Small Cell Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE1
A Phase I/II Study of Sacituzumab Govitecan Plus Berzosertib in Small Cell Lung Cancer, Extra-Pulmonary Small Cell Neuroendocrine Cancer and Homologous Recombination-Deficient Cancers Resistant to PARP Inhibitors
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
Lurbinectedin With Berzosertib, an ATR Kinase Inhibitor in Small Cell Cancers and High-Grade Neuroendocrine Cancers
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
Safety and Clinical Activity of Nivatrotamab in Relapsed/Recurrent Metastatic Small-cell Lung Cancer
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
A First-in-Human, JAB-8263 in Adult Patients With Advanced Tumors
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Anlotinib Plus Etoposide and Carboplatin as First-line Treatment for Extensive-stage Small Cell Lung Cancer
- Status
- UNKNOWN
- Phase
- PHASE2
Feasibility Study on Expandion of MILs From NSCLC and SCLC Patients and Infusion With Pembrolizumab
- Status
- WITHDRAWN
- Phase
- EARLY_PHASE1
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
A Phase I/II Study of Nivolumab, Ipilimumab and Plinabulin in Patients With Recurrent Small Cell Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Study of AZD6738 and Olaparib Combination Therapy in Relapsed Small Cell Lung Cancer Patients [SUKSES-N2]
- Status
- COMPLETED
- Phase
- PHASE2
Whole Brain Radiation Therapy Alone vs. Radiosurgery for SCLC Patients With 1-10 Brain Metastases
- Status
- COMPLETED
- Phase
- NA
Next-generation Sequencing of Small Cell Lung Cancer to Identify Susceptibility Gene and to Assess Treatment
- Status
- UNKNOWN
- Phase
- N/A
Accelerated Hypofractionated vs. Conventionally Fractionated Concurrent CRT for LS-SCLC
- Status
- UNKNOWN
- Phase
- PHASE3
A Phase I/II Study of MEDI4736 in Combination With Olaparib in Patients With Advanced Solid Tumors.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
Pharmacokinetic Study of Lurbinectedin in Combination With Irinotecan in Patients With Selected Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
A Study to Assess the Efficacy and Safety of the VEGFR-FGFR Inhibitor, Lucitanib, Given to Patients With Advanced/Metastatic Lung Cancer and FGF, VEGF, or PDGF Related Genetic Alterations
- Status
- TERMINATED
- Phase
- PHASE2
A Multicenter Phase I Study of MRX34, MicroRNA miR-RX34 Liposomal Injection
- Status
- TERMINATED
- Phase
- PHASE1